Subjects may not understand concept of clinical trials

被引：0
|
作者：
Elbourne, D [1 ]
Snowdon, C [1 ]
Garcia, J [1 ]
机构：
[1] NATL PERINATAL EPIDEMIOL UNIT,OXFORD OX2 6HE,ENGLAND
来源：
BRITISH MEDICAL JOURNAL | 1997年 / 315卷 / 7102期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [1] ACKNOWLEDGMENT OF THE INFORMED CONSENT CONCEPT BY HUMAN SUBJECTS ACTIVELY INVOLVED IN CLINICAL RESEARCH TRIALS
    Stinga, Oana Cristina
    Antonesi, Ioana Maria
    Toma, Anca Iuliana
    [J]. REVISTA ROMANA DE BIOETICA, 2009, 7 (03) : 117 - 126
  • [2] Monitoring human subjects and clinical trials
    Russo, E
    [J]. SCIENTIST, 2000, 14 (10): : 6 - 6
  • [3] CLINICAL-TRIALS IN ELDERLY SUBJECTS
    TURNER, P
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1989, 65 (762) : 218 - 220
  • [4] MURINE CO-CLINICAL TRIALS MAY INFORM HUMAN CLINICAL TRIALS
    不详
    [J]. CANCER DISCOVERY, 2012, 2 (05) : 385 - 385
  • [5] Recruitment of Subjects Into Clinical Trials for Alzheimer Disease
    Knebl, Janice A.
    Patki, Deepti
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (09): : S43 - S49
  • [6] Making clinical trials safer for human subjects
    Baram, M
    [J]. AMERICAN JOURNAL OF LAW & MEDICINE, 2001, 27 (2-3) : 253 - 282
  • [7] Terminating clinical trials without sufficient subjects
    Damen, Lianne
    van Agt, Frans
    de Boo, Theo
    Huysmans, Frans
    [J]. JOURNAL OF MEDICAL ETHICS, 2012, 38 (07) : 413 - 416
  • [8] Using registries to recruit subjects for clinical trials
    Tan, Meng H.
    Thomas, Matthew
    MacEachern, Mark P.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2015, 41 : 31 - 38
  • [9] Understanding incentives for research subjects in clinical trials
    Kazanis, Maryanne
    Kimball, Alexandra
    Armstrong, April
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB78 - AB78
  • [10] Clinical bioavailability trials of pregabalin in healthy subjects
    Sezer, Zafer
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 311 - 312
12345